Clinical Trials
- Digestive System
The OPTIMIZE Trial
- Ages18 years - 80 years
- GenderBoth
- Digestive System
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Ages12 years - 75 years
- GenderBoth
- Digestive System
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Digestive System
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Phase 1 Cancers
A Phase 1B, Open-Label, Dose-Escalation Study of the Safety of and Antigen-specific Immune Responses Elicited by VB10.NEO in Combination With Atezolizumab in Patients With Locally Advanced and Metastatic Tumors
- Liver
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PRIMIS)
- Ages18 years - 75 years
- GenderBoth
- Children's Health, Immune System, Arthritis
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Ages2 years - 21 years
- GenderBoth
- Digestive System, Obesity & Weight Management
Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes after Bariatric Surgery
- Obesity & Weight Management
Yale Dietary Supplement and Weight Management Study
- Ages18 years - 55 years
- GenderBoth
- Leukemia, Pediatric Cancers
A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders
- Ages21 years and younger
- GenderBoth